Vivimed Labs Share Price

Vivimed Labs.

CMP as on 18-May-22 14:39

₹ 14.35
-0.25 -1.71%

Open

₹ 14.80

Turnover (lac)

₹ 19

Prev. Close

₹ 14.60

Day's Vol (shares)

₹ 1,35,365

Day's Range (₹)

₹ 14.15
₹ 14.90

CMP as on18-May-22 14:36

₹ 14.45
-0.15 -1.03%

Open

₹ 14.30

Turnover (lac)

₹ 10

Prev. Close

₹ 14.60

Day's Vol (shares)

₹ 22,111

Day's Range

₹ 14.25
₹ 14.90

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 12-Apr-2022 - -
Vivimed Labs Ltd has informed BSE regarding Outcome of Board Meeting held on April 12, 2022. Outcome of the Meeting of the Board of Directors of the Company
Board Meeting - 02-Feb-2022 - -
VIVIMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 inter alia to consider and approve Notice of Board Meeting / Closure of Trading Window Outcome of the Meeting of the Board of Directors of the Company (As Per BSE Announcement Dated 14.02.2022)
Board Meeting - 27-Oct-2021 - -
Quarterly Results The Board of Directors of the Company at its meeting held on November 13, 2021 inter alia, have approved / resolved/ taken note of the following: 1. Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 considered and approved the submission of the Un-audited Financial Results (Standalone & Consolidated) for the Quarter and half year ended September 30, 2021 attached herewith; 2. Auditorss Limited Review Report on the Un-audited Financial Results of the Company for the quarter and half year ended September 30, 2021. 3. Resignation of CEO cum CFO (Mr.Ramesh Krishnamurthy). (As Per BSE Announcement dated on 13.11.2021)
Board Meeting - 03-Sep-2021 - -
VIVIMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/09/2021 inter alia to consider and approve In terms of the Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 kindly take notice that a meeting of the Board of Directors will be held on Monday September 06 2021 inter-alia consider and approve the proposal to raise capital through (a) issuance of warrants on preferential basis to the Promoters/ Promoter Group entities and other Non- promoters of the Company; (b) issuance of Equity shares on preferential basis/ private placement and (c) QIP/GDR/ADR/FCCB/Other Securities. Outcome of the Meeting of the Board of Directors of the Company (As Per BSE Announcement dated on 06.09.2021)
Board Meeting - 02-Aug-2021 - -
VIVIMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations & Disclosure Requirements), 2015, further to our letter dated 30.06.2021, we hereby bring to your notice that the meeting of the Board of Directors of the Company is scheduled to be held on Friday,13th Day of August, 2021 at Hyderabad inter alia to consider and approve, un-audited Financial Results (Standalone & Consolidated) of the company for the quarter ended 30th June, 2021. Further, we would like to inform that pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the company has intimated its Designated Persons including Directors regarding the closure of trading window from 01.07.2021 to till 48 hours after the declaration of un-audited Financial Results (Standalone & Consolidated) of the company for the quarter ended 30th June, 2021. Kindly take the above information on records. The Board of Directors of the Company at its meeting held on August 13, 2021 inter alia, have approved / resolved/ taken note of the following: 1. Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 considered and approved the submission of the Un-audited Financial Results (Standalone & Consolidated) for the Quarter ended June 30, 2021 attached herewith; 2. Auditorss Limited Review Report on the Un-audited Financial Statements of the Company for the quarter ended June 30, 2021. 3. Directors Report for the financial year ended 31.03.2021 together with annexure thereto. 4. Convening of Annual General Meeting (AGM) on 30.09.2021 and Notice of AGM. 5. Fixed Book closure dates from Saturday, September 25, 2021 to Thursday, September 30, 2021 (both days inclusive) for the purpose of AGM. You are requested to take note of the above. (As per BSE Announcement Dated on 13/8/2021) Vivimed Labs Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 25, 2021 to September 30, 2021 (both days inclusive) for the purpose of Annual General Meeting (AGM) of the Company to be held on September 30, 2021. (As Per BSE Announcement dated on 19.08.2021)
Board Meeting - 16-Jun-2021 - -
VIVIMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/06/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations & Disclosure Requirements), 2015, further to our letter dated 30.03.2021, we hereby bring to your notice that the meeting of the Board of Directors of the Company is scheduled to be held on Monday, 28th Day of June, 2021 at Hyderabad inter alia to consider and approve, audited Financial Results (Standalone & Consolidated) of the company for the quarter and year ended 31st March, 2021. Further, we would like to inform that pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the company has intimated its Designated Persons including Directors regarding the closure of trading window from 01.04.2021 to till 48 hours after the declaration ofaudited Financial Results (Standalone & Consolidated) of the company for the quarter and year ended 31st March, 2021.. Revised Outcome of Board Meeting- Audited financial results for the quarter and year ended 31 March, 2021 (As Per BSE Announcement Dated on 30/06/2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity